Two cases of generalized eruptive lentiginosis in cutaneous T-cell lymphoma following mogamulizumab treatment

Int J Dermatol. 2022 Dec;61(12):e488-e489. doi: 10.1111/ijd.16102. Epub 2022 Jan 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Humans
  • Lentigo*
  • Leukemia-Lymphoma, Adult T-Cell* / pathology
  • Lymphoma, T-Cell, Cutaneous* / chemically induced
  • Lymphoma, T-Cell, Cutaneous* / diagnosis
  • Lymphoma, T-Cell, Cutaneous* / drug therapy
  • Skin Neoplasms* / chemically induced
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / drug therapy

Substances

  • mogamulizumab
  • Antibodies, Monoclonal, Humanized